Fed. Circ. Affirms PTAB Nix Of J&J Unit's Stent Patent
The Federal Circuit on Tuesday affirmed the Patent Trial and Appeal Board's re-examination decision that many claims of a Johnson & Johnson unit's patent on drug-eluting stent technology are invalid, finding...To view the full article, register now.
Already a subscriber? Click here to view full article